MELISSA STEADMAN: Open Payments
NPI 1710506134 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $96 |
| Madrigal Pharmaceuticals | 3 | $80 |
| Exact Sciences Corporation | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $29 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: TREMFYA, REZDIFFRA, Cologuard Collection Kit, SUTAB, XIFAXAN.
Industry payments across NY — which companies pay providers there.
